Glanbia plc — Cyborg Score 7/10

Solid
Nutrition & Functional Ingredients / Sports Nutrition

Strategic Profile

Glanbia maintains dual strategic divisions: Glanbia Performance Nutrition (branded consumer sports supplements) and Glanbia Nutritionals (B2B ingredient solutions for food manufacturers). The company leverages North America as its primary market while expanding globally through specialty retail, e-commerce, gyms, and food-drug-mass channels.

Cyborg Score Rationale

Strong market position in high-growth nutrition segments with diversified brand portfolio and global reach. Recent revenue decline of 29.2% year-over-year (2024) raises operational concerns, though market cap of $4.9B reflects investor confidence in strategic positioning. Recent strategic acquisition (Aroma Holdings, 2024) demonstrates growth ambitions.

Top Insights

  • Dual-model strategy combining direct-to-consumer branded nutrition (Optimum Nutrition, BSN) with B2B ingredient solutions creates revenue diversification
  • Strong presence in North America, largest market, mitigates geographic risk while capturing fastest-growing nutrition segments
  • Portfolio spans performance nutrition, weight management, functional ingredients, and flavor solutions—addressing macro trends in personalized nutrition and clean-label ingredients
  • Strategic acquisitions (Aroma Holdings $300M+, 2024) indicate aggressive product innovation and adjacency expansion strategy

Named Competitors

  • Nutritional Powders & Supplements — Global nutrition company with extensive health science portfolio
  • Functional Ingredients — Global agricultural commodities and ingredients producer
  • Sports Nutrition Brands — Performance nutrition brand portfolio

Recent Developments

  • (April 2024) Acquired Aroma Holding Company, a US flavouring business, for $300M with up to $55M deferred consideration
  • (2024) Revenue declined 29.2% year-over-year to $3.8B; net income declined 52.2% reflecting market headwinds
  • (February 2026) Stock trading at $19.61 with market cap of $4.76B across 242M shares

Open the full interactive Glanbia plc report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →